• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    Athersys, Inc. (ATHX)

    -NasdaqCM
    1.13 0.00(0.00%) Sep 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.13
    Open:1.12
    Bid:1.08 x 1000
    Ask:1.16 x 14600
    1y Target Est:5.25
    Beta:0.083809
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:1.10 - 1.15
    52wk Range:0.90 - 3.43
    Volume:132,791
    Avg Vol (3m):376,738
    Market Cap:93.92M
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ATHX 0.00%93.92M
    OSIRDown 2.06%607.17M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):63.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.33
    Quarterly EPS Est (Sep-15) :-0.07
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback